Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 1 Kaplan-Meier event-free survival at two years for target lesion revascularization (TLR), major adverse coronary events (MACE), and target vessel failure (TVF). p < 0.001 for all comparisons of sirolimus-eluting stent (SES) vs. control bare-metal stent.
|
